FrancophonIA/ELRC3.0 huggingface dataset:
English: In metastatic renal cell carcinoma, patients taking Sutent lived for an average of 47.3 weeks without their disease worsening, compared with 22.0 weeks in the patients receiving interferon alfa.
Latvian: Metastātiskas nieru šūnu karcinomas gadījumā pacienti, kas lietoja Sutent, dzīvoja vidēji 47,3 nedēļas līdz slimība pasliktinājās, salīdzinot ar 22,0 nedēļām pacientiem, kuri lietoja alfa interferonu.
English: This was switched to a full marketing authorisation on 11 January 2007.
Latvian: Šo zāļu reģistrāciju ar nosacījumiem 2007. gada 11. janvārī aizstāja ar parasto reģistrāciju.
English: • pancreatic neuroendocrine tumours (tumours of the hormone-producing cells in the pancreas) that have spread or cannot be removed with surgery.
Latvian: • aizkuņģa dziedzera neiroendokrīnie audzēji (aizkuņģa dziedzera hormonus ražojošo šūnu audzēji), kas izplatījušies vai kas ir neoperējami.
English: The most serious side effects reported with Sutent include heart and kidney failure, pulmonary embolism (clot in a blood vessel supplying the lungs), gastrointestinal perforation (holes in the wall of the gut), and internal haemorrhages (bleeding).
Latvian: Vissmagākās Sutent izraisītās blakusparādības ir sirds mazspēja un nieru disfunkcija, plaušu embolija (plaušu artērijā izveidojies asins receklis), gremošanas trakta perforācija (caurumi zarnu sienā) un iekšējā hemorāģija (asiņošana).
English: • gastrointestinal stromal tumour (GIST), a type of cancer of the stomach and bowel where there is uncontrolled growth of cells in the supporting tissues of these organs.
Latvian: • gastrointestināls stromas audzējs (GISA), kuņģa un zarnu vēža veids, kad notiek nekontrolēta šūnu augšana šo orgānu balstaudos.
English: For the full list of all side effects and restrictions with Sutent, see the package leaflet.
Latvian: Pilns visu Sutent izraisīto blakusparādību un ierobežojumu saraksts ir atrodams zāļu lietošanas instrukcijā.
English: The dose can be adjusted according to the patient's response to the treatment, but should be kept within the range of 25 to 75 mg. For pancreatic neuroendocrine tumours, Sutent is given at a dose of 37.5 mg once a day without a rest period.
Latvian: Devu var pielāgot atkarībā no pacienta reakcijas pret terapiju, bet tai vajadzētu būt 25 līdz 75 mg robežās.
English: How has Sutent been studied?
Latvian: Kā noritēja Sutent izpēte?
English: How does Sutent work?
Latvian: Kā darbojas Sutent?
English: How is Sutent used?
Latvian: Kā lieto Sutent?
English: What is Sutent used for?
Latvian: Kāpēc lieto Sutent?
English: EU number
Latvian: EU numurs
English: OVERALL SUMMARY OF THE SCIENTIFIC EVALUATION OF SANOHEX AND ASSOCIATED NAMES (SEE ANNEX I)
Latvian: SANOHEX UN RADNIECĪGO NOSAUKUMU ZĀĻU ZINĀTNISKĀ NOVĒRTĒJUMA VISPĀRĒJS KOPSAVILKUMS (SKATĪT I PIELIKUMU)
English: 83607 Holzkirchen Germany
Latvian: HEXAL AG, Industriestr. 25, 83607 Holzkirchen Vācija
English: 100 μg/dose
Latvian: 100 µg/devā
English: According to the Applicant, a comparison of the results for the different approaches (individual stages 3, 4 and 5 versus pooled stages 3/4/5) demonstrates that except for stage 3 (below the -15% limit), both approaches lead to comparable results.
Latvian: Pēc pieteikuma iesniedzēja domām dažādu pieeju (atsevišķais 3., 4. un 5. posms pret summētiem posmiem 3./4./5.) rezultātu salīdzinājums parāda to, ka, izņemot 3. posmu (zem 15% robežas), abas pieejas sniedz salīdzināmus rezultātus.
English: The marketing applications were submitted as hybrid applications under Article 10(3) of Directive 2001/83/EC and the EU reference product is Sultanol Dosier-Aerosol 100 μg/dose, Druckgasinhalation, suspension, (GlaxoSmithKline).
Latvian: Reģistrācijas pieteikumi tika iesniegti kā hibrīda pieteikumi saskaņā ar Direktīvas 2001/83/EK 10. panta 3. punktu un ES atsauces zāles ir Sultanol Dosier aerosols inhalācijām ar 100 µg devā, zem spiediena, suspensija (GlaxoSmithKline).
English: The Applicant also decided to generate additional spacer data in order to obtain more reliable information on the particle size distribution when the compared inhalers are fitted with their respective spacer devices.
Latvian: Pieteikuma iesniedzējs arī nolēma izveidot papildu krājtelpas datus, lai iegūtu uzticamāku informāciju par daļiņu lieluma sadalījumu, kad salīdzināmajiem inhalatoriem tiek pievienotas attiecīgās to krājtelpas.
English: Pressurised inhalation, suspension
Latvian: Aerosols inhalācijām, zem spiediena, suspensija inhalācijām
English: Sanohex is a metered dose aerosol inhaler containing a suspension formulation of salbutamol sulphate 100 µg/spray, with HFA 134a as propellant.
Latvian: Sanohex ir dozēts inhalators, kas satur suspensiju no salbutamola sulfāta 100 µg vienā devā kopā ar norfluānu (HFA 134a) kā nesējgāzi.
English: The pharmacokinetic bioequivalence data also confirmed that Sanohex and the reference product possess the same systemic safety profile since bioequivalence in systemic levels (AUC and Cmax) have been shown, when used with or without a spacer.
Latvian: Farmakokinētiskie biolīdzvērtības dati arī apstiprināja to, ka Sanohex un atsauces zālēm ir vienāds sistemātiskais nekaitīguma profils, jo tika parādīta biolīdzvērtība sistemātiskajos līmeņos (laukums zem koncentrācijas-laika līknes un Cmax), izmantojot tos ar vai bez krājtelpas.
English: the CHMP has recommended the granting of the Marketing Authorisations for which the valid Summary of Product Characteristics, labelling and package leaflet are the final versions achieved during the Coordination group procedure are set out in Annex III for Sanohex and associated names (see Annex I).
Latvian: III pielikumā (skatīt I pielikumu) ir atrodama derīga zāļu apraksta, marķējuma teksta un lietošanas pamācības galējā redakcija, kura pieņemta koordinācijas grupas procedūras laikā.
English: - the CHMP considered that Sanohex and the reference product possess the same systemic safety profile, as demonstrated by the bioequivalence in systemic levels (AUC and Cmax),
Latvian: - CHMP uzskatīja, ka tika pierādīts līdzīgs daļiņu lieluma sadalījums pārbaudes un atsauces zālēm, - CHMP uzskatīja, ka Sanohex un atsauces zālēm ir vienāds sistemātiskais nekaitīguma profils, kā to parādīja biolīdzvērtība sistemātiskajos līmeņos (laukums zem koncentrācijas-laika līknes un Cmax), - CHMP nolēma, ka zāles ir biolīdzvērtīgas un ieguvumu un risku attiecība ir pozitīva, CHMP ieteica piešķirt Sanohex un radniecīgu nosaukumu zāļu reģistrācijas apliecību(-as).
English: 1138, Budapest
Latvian: 1138, Budapest Hungary
English: County Mayo Ireland
Latvian: County Mayo Irland
English: 164 94 Kista
Latvian: 164 94 Kista Sweden
English: Sweden Baxter Medical AB Box 63
Latvian: Baxter Medical AB Box 63
English: Avenue louis Pasteur ZA de Coignières Maurepas 78310 Maurepas France
Latvian: Avenue louis Pasteur 78310 ZA de Coignieres 78310 Maurepas France
English: Kifissias Avenue 368, Halandri, 152 33 Greece
Latvian: Diophar SA Kifissias 368 Halandri 15233 Greece
English: List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states
Latvian: Zāļu nosaukumi, zāļu forma, stiprums, lietošanas veids, reģistrācijas apliecības(u) īpašnieks(-i) dalībvalstīs
English: Belgium Baxter SA Boulevard R. Branquart 80 7680 Lessines Belgium
Latvian: Boulevard R. Branquart 80 7680 Lessines Belgium
English: 11 g/l amino acids and 1,25 mmol/l Ca.
Latvian: 11 g/l Aminoskābes and 1,25 mmol/l Ca.
English: Romania BAXTER d.o.o.
Latvian: Rumānija BAXTER d.o.o.
English: Baxter SPA piazzale dell' industria 20 - 00144 Roma, Italy
Latvian: Piazzale dell'Industria 20 00144 Roma Italy
English: Germany Baxter Deutschland GmbH Edisonstr.
Latvian: Baxter Deutschland GmbH Edisonstr. 4
English: L-Alanine 0.951 g/l L-Valine 1.393 g/l
Latvian: L-alanīns 0,951 g/l L-valīns 1,393 g/l
English: Slovak Republic
Latvian: Slovākijas Republikas
English: Denmark Baxter A/S, Gydevang 43, DK-3450 Allerød
Latvian: Baxter A/S Gydevang 43 3450 Allerød Denmark
English: Glucose Monohydrate Ph. Eur.
Latvian: Glikozes monohidrāts Ph. Eur.
English: Norfolk IP24 3SE United Kingdom
Latvian: Thetford IP24 3SE United Kingdom
English: L-Tyrosine Ph.Eur.
Latvian: L-tirozīns Ph.Eur.
English: Baxter AS Gjerdrumsvei 11 0484 Oslo Norway
Latvian: 0484 Oslo, Norway
English: Baxter MédicoFarmacêutica, Lda.
Latvian: Portugāle Baxter Médico Farmacêutica Lda
English: Glucose Monohydrate Ph. Eur.1.1, Sodium Chloride Ph. Eur.
Latvian: Glikozes monohidrāts Ph. Eur.1.1, Nātrija hlorīds Ph. Eur.
English: Luxembourg Baxter SA, Bd René Branquart 80, B-7860 Lessines Belgium
Latvian: Bd René Branquart 80 B-7860 Lessines Belgium
English: Nutrineal PD4 met 11 g/l aminozuren en Ca 1,25 mmol/l, peritoneaaldialysevloeistof
Latvian: Nutrineal PD4 met 11 g/l aminozuren en Ca 1,25 mmol/l, peritoneaaldialysevloeis t of
English: Zelezna cesta 14, SI-1000 Ljubljana
Latvian: Zelezna cesta 14, SI-1000 Ljubljana, Slovenia
English: 4.480 g, Sodium chloride Ph. Eur.
Latvian: 4.480 g, nātrija hlorīds Ph. Eur.
English: Netherlands Baxter B.V., Kobaltweg 49, 3542 CE Utrecht
Latvian: Nīderlande Baxter B.V Kobaltweg 49
English: Baxter Healthcare S.A. Moneen Road Castlebar
Latvian: Baxter Healthcare SA Moneen Road Castlebar
English: Zona Industrial da Abrunheira - Edifício 10Sintra Business Park, 2710-089 Sintra Portugal
Latvian: Edificio 10 Sintra Business Park,
English: 6.43, Calcium Chloride Dihydrate Ph. Eur.
Latvian: 6.43, kalcija hlorīda dihidrāts Ph. Eur.
English: Box 270 Valimotie 15A 00381
Latvian: Box 270 Valimotie 15A 00381 Helsinski Finland
English: Natriumklorid Baxter 9 mg/ml solution for infusion intravenous use
Latvian: Natriumklorid Baxter 9 mg/ml
English: 0.54 % w/v, Sodium (S)-lactate 0.45 % w/v, Calcium Chloride Ph. Eur.
Latvian: 0.54 % w/v, nātrija(S)-laktāts 0.45 % w/v, kalcija hlorīds Ph. Eur.
English: L-Tyrosine 0.300 g/l L-Tryptophan 0.270 g/l L-Phenylalanine 0.570 g/l L-Threonine 0.646 g/l L-Serine 0.510 g/l
Latvian: L-tirozīns 0,300 g/l L-triptofāns 0,270 g/l L-fenilanalīns 0,570 g/l L-treonīns 0,646 g/l L-serīns 0,510 g/l
English: 0.714 g L-Arginine Ph.Eur.
Latvian: 0.714 g L-arginīns Ph.Eur.
English: Invented name
Latvian: Zāļu nosaukums
English: 1.071 g, Calcium chloride dihydrate Ph.Eur.
Latvian: 1.071 g, kalcija hlorīda dihidrāts Ph.Eur.
English: 7,5% (icodextrin)
Latvian: 7,5% (Ikodekstrīns)
English: Hungary Baxter Hungary Kft. Népfürdő u. 22.
Latvian: Baxter Hungary Kft.
English: 0.646 g, L-Serine Ph.Eur.
Latvian: 0.646 g, L-serīns Ph.Eur.
English: Icodextrin 7.5 % w/v, Sodium Chloride Ph.
Latvian: Ikodekstrīns 7.5 % w/v, nātrija hlorīds Ph.
English: 1.1, Sodium Chloride Ph. Eur.
Latvian: 1.1, Nātrija hlorīds Ph. Eur.
English: Anhydrous Glucose Ph.Eur.
Latvian: Bezūdens glikoze Ph.Eur.
English: 75.00 g/l Icodextrine
Latvian: 75.00 g/l Ikodekstrīns
English: 0.152, Sodium Lactate Ph. Eur.
Latvian: 0.152, nātrija laktāts Ph. Eur.
English: Thetford,
Latvian: Abrunheira,
English: 0.184 g, Magnesium chloride hexahydrate Ph.Eur.
Latvian: 0.184 g, magnija hlorīda heksahidrāts Ph.Eur.
English: 0.951 g, L-Valine Ph.Eur.
Latvian: 0.951 g, L-valīns Ph.Eur.
English: 1,1% amino acid
Latvian: 1,1% Aminoskābes
English: 0.0257 % w/v, Magnesium Chloride Ph. Eur.
Latvian: 0.0257 % w/v, magnija hlorīds Ph. Eur.
English: 0.850 g, L-Isoleucine Ph.Eur.
Latvian: 0.850 g, L-izoleicīns Ph.Eur.
English: 7,5 % 75 g / 1000 ml peritoneal use
Latvian: 7,5 % 75g/1000 ml
English: solution for haemodialysis, haemodiafiltration and haemofiltration intraarterial use, intravenous use, hemodialysis
Latvian: Intraarteriālai lietošanai, intravenozai lietošanai, hemodialīzei
English: Lithuania Baxter Oy, P.O.
Latvian: Baxter Oy P.O.
English: Slovenia Baxter d.o.o., Zelezna cesta 18 , Ljubljana, SI-1000, Slovenia
Latvian: Slovēnija Baxter d.o.o., Zelezna cesta 18 ,Ljubljana, SI-1000, Slovenia
English: 3.36, Potassium Chloride Ph. Eur.
Latvian: 3.36, kālija hlorīds Ph. Eur.
English: 75 g/l icodextrine
Latvian: 75 g/l Ikodekstrīns
English: Nutrineal PD4 with 1.1% Amino Acids tyrosine 0.03%w/v; tryptophan 0.027%w/v; phenylalanine 0.057%w/v; threonine 0.064%w/v; L-serine 0.051%w/v; L-proline 0.058%w/v; glycine 0.051%w/v; L-alanine 0.095%w/v; valine 0.139%w/v; methionine 0.085%w/v; isoleucine 0.085%w/v; leucine 0.102%w/v; lysine 0.095%w/v; histidine 0/071%w/v; arginine 0.107%w/v; calcium chloride 0.018%w/v; magnesium chloride 0.005%w/v; sodium chloride 0.538%w/v; sodium s-lactate 0.448%w/v
Latvian: Nutrineal PD4 with 1.1% Amino Acids tirozīns 0,03% w/v; triptofāns 0,027% w/v; fenilanalīns 0,057% w/v; treonīns 0,064% w/v; L-serīns 0,051% w/v; L-prolīns 0,058% w/v; glicīns 0,051% w/v; L-alanīns 0,095% w/v; valīns 0,139% w/v; metionīns 0,085% w/v; izoleicīns 0,085% w/v; leicīns 0,102% w/v; lizīns 0,095% w/v; histidīns 0,071% w/v; arginīns 0,107% w/v; kalcija hlorīds 0,018% w/v; magnija hlorīds 0,005% w/v; nātrija hlorīds 0,538% w/v; nātrija S laktāts 0,448% w/v
English: L-Methionine 0.850 g/l L-Isoleucine 0.850 g/l L-Leucine 1.020 g/l L-Lysine (chlorhydrate) 0.955 g/l L-Histidine 0.714 g/l L-Arginine 1.071 g/l Calcium chloride dihydrate 0.184 g/l Magnesium chloride hexahydrate 0.051 g/l Sodium Lactate 4.48 g/l
Latvian: L-metionīns 0,850 g/l L-izoleicīns 0,850 g/l L-leicīns 1,020 g/l L-lizīns (hlorhidrāts) 0,955 g/l L-histidīns 0,714 g/l L-arginīns 1,071 g/l Kalcija hlorīda dihidrats 0,184 g/l Magnija hlorīda heksahidrāts 0,051 g/l
English: 3.86 % w/v or Glucose Monohydrate Ph.Eur.
Latvian: 3,86% w/v vai glikozes monohidrāts Ph.Eur.
English: 22,7 g/l glucose anhydrate
Latvian: 22.7 g/l Bezūdens glikozes
English: 0.257, Magnesium Chloride Hexahydrate Ph. Eur.
Latvian: 0.257, magnija hlorīda heksahidrāts Ph.
English: 0.39 % w/v Calcium Chloride Ph.Eur.
Latvian: 0,39% w/v, kalcija hlorīds Ph.Eur.
English: 0.448 % w/v Calcium Chloride Ph.Eur.
Latvian: 0,448% w/v, kalcija hlorīds Ph.Eur.
English: 0.270 g, L-Phenylalanine Ph.Eur.
Latvian: 0.270 g, Lfenilalanīns Ph.Eur.
English: 0.538 % w/v Sodium Lactate Ph.Eur.
Latvian: 0,538% w/v, nātrija laktāts Ph.Eur.
English: 0.955 g, LHistidine Ph.Eur.
Latvian: 0.955 g, Lhistidīns Ph.Eur.
English: Baxter Oy Valimotie 15 A 00381 Helsinki Finland
Latvian: Box 270 Valimotie 15A 00381 Helsinki Finland
English: 0.051 g, Sodium-lactate Ph.Eur.
Latvian: 0.051 g, nātrija-laktāts Ph.Eur.
English: 2.27 % w/v or Glucose Monohydrate Ph.Eur.
Latvian: 2,27% w/v vai glikozes monohidrāts Ph.Eur.
English: Baxter Healthcare Ltd., Caxton Way, Thetford,
Latvian: Baxter Healthcare Ltd Caxton Way,
English: 1.36 % w/v or Glucose Monohydrate Ph.Eur.
Latvian: 1,36% w/v vai glikozes monohidrāts Ph.Eur.
English: 38,6 g/l glucose anhydrate
Latvian: 38.6 g/l Bezūdens glikozes
English: Baxter Healthcare S.A. Moneen Road Castlebar, Co. Mayo Ireland
Latvian: Moneen Road Castlebar, CO. Mayo Ireland
English: 0.510 g, L-Proline Ph.Eur.
Latvian: 0.510 g, L-prolīns Ph.Eur.
English: Icodextrin (75 g/l), Sodium chloride (5.4 g/l), Calcium chloride (0.257 g/l), Magnesium chloride (0.051 g/l), Sodium lactate solution (4.5 g/l)
Latvian: Ikodekstrīns (75 g/l), nātrija hlorīds (5,4 g/l), kalcija hlorīds (0,257 g/l), magnija hlorīds (0,051 g/l), nātrija laktāta šķīdums (4.5 g/l)
English: DIOPHAR S.A.
Latvian: Baxter S.A.
English: 0.0184 % w/v Magnesium Chloride Ph.Eur.
Latvian: 0,0184 w/v, magnija hlorīds Ph.Eur.
English: 0.57 % w/v Sodium Lactate Ph.Eur.
Latvian: 0,57% w/v, nātrija laktāts Ph.Eur.
English: Nutrineal PD4 mit 1,1 % AminosäurenPeritonealdialyselösung alanine 951 mg/L, arginine 1071 mg/L, glycine 510 mg/L, histidine 714 mg/L, isoleucine 850 mg/L, leucine 1020 mg/L, lysine hydrochloride 955 mg/L, methionine 850 mg/L, phenylalanine 570 mg/L, proline 595 mg/L, serine 510 mg/L, threonine 646 mg/L, tryptophan 270 mg/L, tyrosine 300 mg/L, valine 1393 mg/L, sodium chloride 5380 mg/L, calcium chloride dihydrate 184 mg/L, magnesium chloride hexahydrate 51 mg/L, sodium(s)-lactate 4480 mg/L
Latvian: Nutrineal PD4 mit 1,1 % AminosäurenPeritonealdialyselösung alanīna 951 mg/L, arginīns 1071 mg/L, glicīns 510 mg/L, histidīns 714 mg/L, izoleicīns 850 mg/L, leicīns 1020 mg/L, lizīna hidrohlorīds 955 mg/L, metionīnu 850 mg/L, fenilalanīna 570 mg/L, Prolīna 595 mg/L, serīna 510 mg/L, treonīns 646 mg/L, triptofāns 270 mg/L, tirozīns 300 mg/L, valīns 1393 mg/L, Nātrija hlorīds 5380 mg/L, Kalcija hlorīds 184 mg/L, Magnija hlorīds 51 mg/L, Nātrija (S) laktāts 4480 mg/L
English: 0.595 g, Glycine Ph.Eur.
Latvian: 0.595 g, glicīns Ph.Eur.
English: 0.300 g, L-Tryptophan Ph.Eur.
Latvian: 0.300 g, Ltriptoāns Ph.Eur.
English: 1.020 g, LLysine hydrochloride Ph.Eur.
Latvian: 1.020 g, L-lizīna hidrohlorīds Ph.Eur.
English: 13,6 g/l glucose anhydrate
Latvian: 13.6 g/l Bezūdens glikozes
English: 1,071 mg/ml Arginine; 0,714 mg/ml Histine; 0,955 mg/ml Lysine hydrochloride; 1,02 mg/ml Leucine; 0,85 mg/ml Isoleucine; 0,85 mg/ml Methionine; 1,393 mg/ml Valine; 0,951 mg/ml Alanine; 0,51 mg/ml Glycine; 0,595 mg/ml Proline; 0,51 mg/ml Serine; 0,646 mg/ml Threonine; 0,57 mg/ml Phenylalanine; 0,27 mg/ml Tryptophan; 0,3 mg/ml Tyrosine; 0,184 mg/ml Calcium Chloride Dihydrate; 0,051 mg/ml Magnesium Chloride Hexahydrate; 5,38 mg/ml Sodium Chloride; 4,48 mg/ml Sodium Lactate
Latvian: 1,071 mg/ml arginīns; 0,714 mg/ml histidīns; 0,955 mg/ml lizīna hidrohlorīds; 1,02 mg/ml leicīns; 0,85 mg/ml izoleicīns; 0,85 mg/ml metionīns; 1,393 mg/ml valīns; 0,951 mg/ml alanīns; 0,51 mg/ml glicīns; 0,595 mg/ml prolīns; 0,51 mg/ml serīns; 0,646 mg/ml treonīns; 0,57 mg/ml fenilanalīns; 0,27 mg/ml triptofāns; 0,3 mg/ml tirozīns; 0,184 mg/ml kalcija hlorīda dihidrāts; 0,051 mg/ml magnija hlorīda heksahidrāts; 5,38 mg/ml kalcija hlorīds; 4,48 mg/ml nātrija laktāts
English: 1.393 g, LMethionine Ph.Eur.
Latvian: 1.393 g, L-metionīns Ph.Eur.
English: 0.0257 % w/v Magnesium Chloride Ph.Eur.
Latvian: 0,0257 w/v, magnija hlorīds Ph.Eur.
English: 4.25 % w/v Sodium Chloride Ph.Eur.
Latvian: 4,25% w/v, nātrija hlorīds Ph.Eur.
English: Extraneal (Icodextrin 7.5%) Solution for peritoneal dialysis icodextrin 75g/l; sodium chloride 5.4g/l; calcium chloride 0,257g/l; magnesium chloride 0.051g/l; sodium s-lactate 4.5g/l
Latvian: Ikodekstrīns 75g/l; nātrija hlorīds 5,4g/l; kalcija hlorīds 0,257g/l; magnija hlorīds 0,051g/l; nātrija S laktāts 4.5g/l
English: 1.50 % w/v Sodium Chloride Ph.Eur.
Latvian: 1,50% w/v, nātrija hlorīds Ph.Eur.
English: solution for dialysis peritoneal
Latvian: Solution for peritoneal dialysis
English: Romania BAXTER HEALTHCARE S.A. Moneen Road, Castelbar, County Mayo
Latvian: Rumānija Baxter Healthcare SA, Moneen Road, Castlebar, Co.
English: 0.510 g, L-Alanine Ph.Eur.
Latvian: 0.510 g, Lalanīns Ph.Eur.
English: Dianeal PD1 Glucose 2.27%/22,7 mg/ml, peritoneaaldialysevloeistof
Latvian: Dianeal PD1 Glucose 2.27%/22,7 mg/ml, peritoneaaldialysevloeis t of
English: 75 mg/ml Icodextrin; 5,4 mg/ml Sodium Chloride; 4,5 mg/ml Sodium (S) - lactate solution; 0,051 mg/ml Magnesium Chloride; 0,257 mg/ml Calcium Chloride
Latvian: 75 mg/ml ikodekstrīns; 5,4 mg/ml nātrija hlorīds; 4,5 mg/ml nātrija S laktāta šķīdums; 0,051 mg/ml magnija hlorīds; 0,257 mg/ml kalcija hlorīds
English: Calcium Chloride: 0.026% w/v. glucose 0.110%w/v; sodium lactate 0.336%w/v; sodium chloride 0.643%w/v; magnesium chloride 0.015%w/v solution for haemodialysis/hae mofiltration intraarterial use, intravenous use
Latvian: Kalcija hlorīds: 0.026% w/v. glikoze 0.110%w/v; nātrija laktāts 0.336%w/v; nātrija hlorīds 0.643%w/v; magnija hlorīds 0.015%w/v
English: L-Proline 0.595 g/l
Latvian: L-prolīns 0,595 g/l Glicīns 0,510 g/l
English: Dianeal PD1 Glucose 3.86%/38,6 mg/ml, peritoneaaldialysevloeistof
Latvian: Dianeal PD1 Glucose 3.86%/38,6 mg/ml, peritoneaaldialysevloeis t of
English: 2.50 % w/v Sodium Chloride Ph.Eur.
Latvian: 2,50% w/v, nātrija hlorīds Ph.Eur.
English: Dianeal PD1 Glucose 1.36%/13,6 mg/ml, peritoneaaldialysevloeistof
Latvian: Dianeal PD1 Glucose 1.36%/13,6 mg/ml, peritoneaaldialysevloeis t of
English: 0.570 g, L-Threonine Ph.Eur.
Latvian: 0.570 g, Ltreonīns Ph.Eur.
English: Finland Baxter Healthcare S.A. Moneen Road, Castlebar County Mayo
Latvian: Baxter Healthcare SA Moneen Road Castlebar, County Mayo Ireland
English: Dianeal PD4 Glucose 2.27%/22,7 mg/ml, peritoneaaldialysevloeistof
Latvian: Dianeal PD4 Glucose 2.27%/22,7 mg/ml, peritoneaaldialysevloeis t of
English: Dianeal PD1 Glucose 2.27% w/v /22.7mg/ml sodium chloride 0.57%w/v; glucose 2.27%w/v; magnesium chloride 0.015%w/v; sodium lactate 0.39%w/v; calcium chloride 0.026%w/v
Latvian: Thetford IP24 3SE United Kingdom nātrija hlorīds 0.57%w/v; glikoze 2,27%w/v; magnija hlorīds 0.015%w/v; nātrija laktāts 0.39%w/v; kalcija hlorīds 0.026%w/v
English: Baxter Healthcare SA Moneen Rd Castlebar, Co. Mayo Ireland
Latvian: Baxter Healthcare SA, Moneen Rd, Castlebar, Co.
English: Dianeal PD4 Glucose 1.36%/13,6 mg/ml, peritoneaaldialysevloeistof
Latvian: Dianeal PD4 Glucose 1.36%/13,6 mg/ml, peritoneaaldialysevloeis t of
English: magnesium chloride 0.015%w/v; potassium chloride 0.029%w/v; calcium chloride 0.026%w/v; sodium lactate 0.336%w/v; sodium chloride 0.643%w/v; glucose 0.110%w/v solution for haemodialysis/hae mofiltration intraarterial use, intravenous use
Latvian: magnija hlorīds 0.015%w/v; kālija hlorīds 0.029%w/v; kalcija hlorīds 0.026%w/v; nātrija laktāts 0.336%w/v; nātrija hlorīds 0.643%w/v; glikoze 0.110%w/v
English: Dianeal PD4 Glucose 3.86%/38,6 mg/ml, peritoneaaldialysevloeistof
Latvian: Dianeal PD4 Glucose 3.86%/38,6 mg/ml, peritoneaaldialysevloeis t of
English: sodium chloride 0.643%w/v; magnesium chloride 0.015%w/v; calcium chloride 0.026%w/v; glucoae 0.110%w/v; potassium chloride 0.015%w/v; sodium lactate 0.336%w/v solution for haemodialysis/hae mofiltration intraarterial use, intravenous use
Latvian: Nātrija hlorīds 0.643%w/v; magnija hlorīds 0.015%w/v; kalcija hlorīds: 0.026%w/v; glikoze 0.110%w/v; kālija hlorīds 0.015%w/v; nātrija laktāts 0.336%w/v
English: Anhydrous glucose 22.7 g/L, sodium chloride 5.38 g/L, sodium-L(+) lactate 4.48 g/L, calcium chloride dihydrate 0.184 g/L, magnesium chloride hexahydrate 0.051 g/L
Latvian: Bezūdens glikozes 22.7 g/L, Nātrija hlorīds 5.38 g/L, Nātrija (S) laktāts 4.48 g/L, Kalcija hlorīds 0,184 g/L, Magnija hlorīds 0,051 g/L
English: 22,7g+5,38g+4,48g+0,184g+0,051g/l
Latvian: Dianeal PD4 Glucose 22,7g+5,38g+4,48g+0,184g+0,051 g/l
English: 3,86% w/v 0,538% w/v 0,448% w/v 0,0184% w/v 0,0051% w/v
Latvian: 3,86% w/v 0,538% w/v 0,448% w/v
English: 42,5 mg/ml Glucose Monohydrate; 5,38 mg/ml Sodium Chloride; 0,184 mg/ml Calcium Chloride Dihydrate; 0,051 mg/ml Magnesium Chloride Hexahydrate; 4,48 mg/ml Sodium Lactate
Latvian: 42,5 mg/ml glikozes monohidrāts; 5,38 mg/ml nātrija hlorīds; 0,184 mg/ml kalcija hlorīda dihidrāts; 0,051 mg/ml magnija hlorīda heksahidrāts; 4,48 mg/ml nātrija laktāts
English: 1,36% w/v 0,538% w/v 0,448% w/v 0,0184% w/v 0,0051% w/v
Latvian: 1,36% w/v 0,538% w/v 0,448% w/v
English: Anhydrous glucose 38.6 g/L, sodium chloride 5.38 g/L, sodium-L(+) lactate 4.48 g/L, calcium chloride dihydrate 0.184 g/L, magnesium chloride hexahydrate 0.051 g/L
Latvian: Bezūdens glikozes 38.6 g/L, Nātrija hlorīds 5.38 g/L, Nātrija (S) laktāts 4.48 g/L, Kalcija hlorīds 0,184 g/L, Magnija hlorīds 0,051 g/L
English: Anhydrous glucose 13.6 g/L, sodium chloride 5.38 g/L, sodium-L(+) lactate 4.48 g/L, calcium chloride dihydrate 0.184 g/L, magnesium chloride hexahydrate 0.051 g/L
Latvian: Bezūdens glikozes 13.6 g/L, Nātrija hlorīds 5.38 g/L, Nātrija (S) laktāts 4.48 g/L, Kalcija hlorīds 0,184 g/L, Magnija hlorīds 0,051 g/L
English: 00381 Finland
Latvian: 0484 Oslo
English: 15 mg/ml Glucose Monohydrate; 5,38 mg/ml Sodium Chloride; 0,184 mg/ml Calcium Chloride Dihydrate; 0,051 mg/ml Magnesium Chloride Hexahydrate; 4,48 mg/ml Sodium Lactate
Latvian: 15 mg/ml glikozes monohidrāts; 5,38 mg/ml nātrija hlorīds; 0,184 mg/ml kalcija hlorīda dihidrāts; 0,051 mg/ml magnija hlorīda heksahidrāts; 4,48 mg/ml nātrija laktāts
English: 42,5 mg/ml Glucose Monohydrate; 5,67 mg/ml Sodium Chloride; 0.257 mg/ml Calcium Chloride Dihydrate; 0,152 mg/ml Magnesium Chloride Hexahydrate; 3,92 mg/ml Sodium Lactate
Latvian: 42,5 mg/ml glikozes monohidrāts; 5,67 mg/ml nātrija hlorīds; 0,257 mg/ml kalcija hlorīda dihidrāts; 0,152 mg/ml magnija hlorīda heksahidrāts; 3,92 mg/ml nātrija laktāts